48,830
edits
Difference between revisions of "Amyloid"
Jump to navigation
Jump to search
→Associations - DDx: wikify
(→Associations - DDx: wikify) |
(→Associations - DDx: wikify) |
||
| Line 44: | Line 44: | ||
*Malignancy. | *Malignancy. | ||
**[[Plasmacytoma]]. | **[[Plasmacytoma]]. | ||
***5-15% of patients with multiple myeloma develop amyloidosis<ref>{{Ref_PBoD|261}}</ref> - some say 10-20%.<ref name=merck>Amyloidosis. Merck Manual. URL: [http://www.merck.com/mmpe/sec12/ch160/ch160a.html http://www.merck.com/mmpe/sec12/ch160/ch160a.html]. Accessed on: 3 December 2009.</ref> | ***5-15% of patients with [[multiple myeloma]] develop amyloidosis<ref>{{Ref_PBoD|261}}</ref> - some say 10-20%.<ref name=merck>Amyloidosis. Merck Manual. URL: [http://www.merck.com/mmpe/sec12/ch160/ch160a.html http://www.merck.com/mmpe/sec12/ch160/ch160a.html]. Accessed on: 3 December 2009.</ref> | ||
**[[Medullary thyroid carcinoma]]. | **[[Medullary thyroid carcinoma]]. | ||
**[[Renal cell carcinoma]]. | **[[Renal cell carcinoma]]. | ||